Published in Allergy Asthma Clin Immunol on November 01, 2013
Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol (2011) 1.78
Allergic rhinitis. Lancet (2011) 1.74
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther (1997) 1.44
Activation of human mast cells through the platelet-activating factor receptor. J Allergy Clin Immunol (2010) 1.08
Rupatadine and levocetirizine for seasonal allergic rhinitis: a comparative study of efficacy and safety. Arch Otolaryngol Head Neck Surg (2010) 0.97
Rupatadine and levocetirizine in chronic idiopathic urticaria: a comparative study of efficacy and safety. J Drugs Dermatol (2011) 0.85
Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor. J Allergy Clin Immunol (1994) 0.85
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. Allergy (2000) 0.84
Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. Br J Dermatol (2010) 0.84
Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein. Eur Respir J (1994) 0.82
Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways. Am Rev Respir Dis (1989) 0.81
Eosinophil chemotactic activity of topical PAF on the human nasal mucosa. Eur J Clin Pharmacol (1992) 0.81
Acoustic rhinometry in the practice of allergy. Ann Allergy Asthma Immunol (2006) 0.80
Study of the effects of paf-acether on human nasal airways. Allergy (1991) 0.80
Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. Am J Rhinol Allergy (2013) 0.79